Ranbaxy Laboratories has recalled Atorvastatin from the USA market which will cause temporary disruption to the market of this product. The investigation with regard to the same is expected to be completed within two weeks and thereafter the company expects to resume supplies.
Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.
